Cargando…
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
Coronavirus disease 2019 (COVID-19) pandemic has become challenging even for the most durable healthcare systems. It seems that vaccination, one of the most effective public-health interventions, presents a ray of hope to end the pandemic by achieving herd immunity. In this review, we aimed to cover...
Autores principales: | Velikova, Tsvetelina, Georgiev, Tsvetoslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846902/ https://www.ncbi.nlm.nih.gov/pubmed/33515320 http://dx.doi.org/10.1007/s00296-021-04792-9 |
Ejemplares similares
-
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023) -
COVID-19 related liver injuries in pregnancy
por: Sekulovski, Metodija, et al.
Publicado: (2023) -
Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control
por: Velikova, Tsvetelina V., et al.
Publicado: (2021) -
Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression
por: Georgiev, Tsvetoslav, et al.
Publicado: (2020) -
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease
por: Peshevska-Sekulovska, Monika, et al.
Publicado: (2022)